Life Sciences Digital Summit:Coding Innovation Into Our DNA
Life Sciences Summit
Many life sciences companies have experienced growth and are emboldened with stronger balance sheets from which to invest. 2022 will see significant investments in their portfolios, including next generation therapies and investments, to capitalize on their digital progress. With access to a myriad of tools to gather and analyze data, it’s time for life sciences companies to employ digitalization at scale. Everything from research and development (R&D), to commercial processes, to supply chain, to human resources is being reimagined, digitized, and transformed at a pace that we have not seen in years past.
Why Attend
New connections
Build new connections with likeminded senior leaders
Business trends
Stay current with emerging business trends
Key takeaways
Downloadable and actionable takeaways
New partnerships
Accelerate key projects through meaningful new partnerships
Insights
De-risk new projects by gaining a broad range of insights
New technologies
Understand the impact new technology can make
Trusted by
We host global organizations with the conversations that matter. That’s why we’re trusted by these top brands.
Past Programme
09:00 - 09:15
Opening Remarks
Intro & Diamond Commentary
09:15 - 09:45
Keynote
Driving organisational transformation through digital transformation
Given the fact that many digital transformation projects fail it is quite exciting when a project not only succeeds but leads to an organisational transformation as well. Join us for an exciting keynote focussing on how digital is driving revenue generation in Life Sciences
09:45 - 10:25
Panel Discussion
Transforming outcomes in digital health
Given the exciting potential of digital health it is critical for companies to ask difficult questions around whether digital experiences currently replace or even compliment human touch and connection. Join this exciting panel as they focus on the current outcomes being brought by digital health and what new approaches and strategies need to be embraced for it to deliver better for patients.
10:25 - 10:35
Insight Break
10:35 - 11:25
Roundtables
Track 1: Scaling digital for end-to-end transformation: Continued accelerated growth and record investment
In 2022 life sciences organisations are ramping up their efforts to digitize virtually every business function. Everything from research and development (R&D), to commercial processes, to supply chain, to human resources is being reimagined, digitized, and transformed at a pace that we have not seen in years past. A scattershot approach to digital will no longer work for those who want to succeed in driving business value and delivering customer- and patient-centric experiences. Biopharma and medtech companies are expected to evolve from just doing digital—to being digital
•What is the difference between digital optimisation and digital transformation in life sciences? Is modernizing processes/systems across the entire value chain and in core functions enough?
•What are the key challenges in scaling up emerging technology in the life sciences when considering regulation, privacy and patient protection?
Track 2: Enabling technology to get closer to the customer to create personalised experiences
The digital channels that were created almost in a hurry during the early stages of the pandemic are not going to be competitive in a digital first marketplace. New solutions have to be frictionless but more importantly they have to meet the changing appetites of customers driven largely by personalisation. To ensure that companies create patient centric products, digital will have to become a strategic priority. More importantly, IT will have to put the end user in mind when enabling and supporting cross functional teams to deliver outcomes that transform the patient health and experience.
•How can IT leaders drive customer centricity in their teams through cross functional projects and multi-disciplinary teams
•How can the connected patient transform outcomes and what are the key challenges facing technology leaders in achieving this?
•Where is AI capability currently supporting personalised experience and what data and analysis practices will drive this?
Track 3: Leading a frictionless employee experience to develop critical capabilities and drive innovation
The pandemic is now fully normalised in most peoples lives. As a result, the excuse it offered for IT to provide sub-optimal IT experiences is no longer available. No matter where people work or how they work, they expect a frictionless experience. The stakes are even higher now given that as the pandemic has waned and it has given rise to the great resignation where general tech but more importantly critical data and analytics skills can be lost due to a poor experience.
The life sciences industry is being transformed through data and they have to secure key capabilities to be competitive. Given that they are competing with all other sectors for already scare talent they will need to use technology to deliver key insights while also harnessing it to reskill existing employees.
•How is the post-pandemic workplace creating challenges for IT in delivering a frictionless and engagement friendly IT experience ?
•What critical workplace tools are enhancing the way that hybrid and even office based teams collaborate and innovate? Where is this not about technology but about leadership and culture?
•Given the huge need for data literacy and reskilling, what platforms enable peer support, social learning and career mobility?
11:25 - 11:30
Short Break
11:30 - 12:10
Masterclass Breakouts
Track 1: The Future of Data & Analytics – Reengineering the Decision, 2025
Track 2: Smart Pharmaq Manufacturing
Smart manufacturing holds the most promise to transform the manufacturing operations of all life science companies. For this major Pharma company who started this journey before many of its peers, the journey has been challenging with many panful lessons on the way. This masterclass will look at the succesful strategies for scaling digital twin, AI and IOT to achieve Industry 4.0
12:11 - 12:41
Headline Keynote
Driving engagement, retention and innovation through a frictionless employee IT experience
09:00 - 09:10
Opening Remarks
09:10 - 09:40
Keynote
Curating health through technology - Putting CX at the heart of DX strategy in life sciences
We live in an experience economy and given the rise of digital health this represents an even bigger opportunity for traditional life science manufacturers, who can cut straight to the consumer in how their treatments are tested, prescribed, administered and managed over a whole treatment arc. In this talk from a cutting edge CX leader you can understand how the competitive landscape is forcing technology leaders to enable world class healing experiences to patients.
09:42 - 10:22
Panel Discussion
The next bold step - Driving data cultures within Lifesciences
Data has been the unsung hero of the recent transformation in Life Sciences. Organizations that are developing quality data-driven strategies and cultures are developing fully integrated products that are transforming the experiences of patients. In this panel we learn from some of the Life Science industries most dynamic data leaders on what is the next bold step for data at this very exciting time.
10:22 - 10:32
Insight Break
10:35 - 11:25
Roundtables
Track 1: Scaling digital for end-to-end transformation: Continued accelerated growth and record investment
In 2022 life sciences organisations are ramping up their efforts to digitize virtually every business function. Everything from research and development (R&D), to commercial processes, to supply chain, to human resources is being reimagined, digitized, and transformed at a pace that we have not seen in years past. A scattershot approach to digital will no longer work for those who want to succeed in driving business value and delivering customer- and patient-centric experiences. Biopharma and medtech companies are expected to evolve from just doing digital—to being digital
•What is the difference between digital optimisation and digital transformation in life sciences? Is modernizing processes/systems across the entire value chain and in core functions enough?
•What are the key challenges in scaling up emerging technology in the life sciences when considering regulation, privacy and patient protection?
Track 2: Enabling technology to get closer to the customer to create personalised experiences
The digital channels that were created almost in a hurry during the early stages of the pandemic are not going to be competitive in a digital first marketplace. New solutions have to be frictionless but more importantly they have to meet the changing appetites of customers driven largely by personalisation. To ensure that companies create patient centric products, digital will have to become a strategic priority. More importantly, IT will have to put the end user in mind when enabling and supporting cross functional teams to deliver outcomes that transform the patient health and experience.
•How can IT leaders drive customer centricity in their teams through cross functional projects and multi-disciplinary teams
•How can the connected patient transform outcomes and what are the key challenges facing technology leaders in achieving this?
•Where is AI capability currently supporting personalised experience and what data and analysis practices will drive this?
Track 3: Leading a frictionless employee experience to develop critical capabilities and drive innovation
The pandemic is now fully normalised in most peoples lives. As a result, the excuse it offered for IT to provide sub-optimal IT experiences is no longer available. No matter where people work or how they work, they expect a frictionless experience. The stakes are even higher now given that as the pandemic has waned and it has given rise to the great resignation where general tech but more importantly critical data and analytics skills can be lost due to a poor experience.
The life sciences industry is being transformed through data and they have to secure key capabilities to be competitive. Given that they are competing with all other sectors for already scare talent they will need to use technology to deliver key insights while also harnessing it to reskill existing employees.
•How is the post-pandemic workplace creating challenges for IT in delivering a frictionless and engagement friendly IT experience ?
•What critical workplace tools are enhancing the way that hybrid and even office based teams collaborate and innovate? Where is this not about technology but about leadership and culture?
•Given the huge need for data literacy and reskilling, what platforms enable peer support, social learning and career mobility?
11:26 - 11:56
Innovation Exchange Keynote
ESG & Life Sciences
ESG is the biggest corporate strategy trend since digital transformation and this masterclass explores the key links between the two themes and what senior technology leaders need to be aware of.
12:05 - 12:35
Closing Prime Keynote
Security Innovation in the Healthcare Market Place
Counterfeit is one of the biggest challenges facing life science companies as digital and incresingly distributed health becomes more established. Learn from Afero is they reveal a unique technology that is giving customers and the providers that spends billions to innovate the peace of mind that they are using the genuine article.
09:00 - 09:10
Opening Remarks
09:10 - 09:40
Keynote
Driving innovation throuth effective cloud strategy
09:41 - 10:21
Panel Discussion
Harnessing innovation cultures in Lifesciences to drive digital transformation
Life science companies have been very innovative when it comes to developing new molecules but their track record on digital transformation is less impressive. What is the low hanging fruit. We consider perspectives from leaders driving incubation, new ventures and the execution of new digital health tools.
10:22 - 10:32
Insight Break
10:32 - 11:22
Roundtable Leaders Panel
11:22 - 11:30
Short Break
11:30 - 12:00
Innovation Exchange Keynote
Developing the workforce of the future
The Life Sciences sector is enjoying one of its most exciting periods as the promise of personalised medicines and gene and cell therapies gets realised. These exciting breakthroughs have been made possible through rapid technological breakthroughs and people harnessing the power of data in new ways. The critical challenge is ensuring that organisations have the access to human talent to adopt and automate these new technologies while providing the creative problem solving where algorithms fall short. To secure the key capabilities to deliver innovation, leaders need to understand not only how to attract talent but how to develop the workforce of the future. Jenny Ligon and her team at The National Centre for Therapeutics Manufacturing have helped companies reskill thousands of individuals – from Starbucks baristas to PhDs – to ensure our nation was able to develop precious vaccines quick enough. Two years on she moderates an exciting conversation with various pharmaceutical manufacturing leaders around what the workforce of the future looks like and what is required to attract, develop and retain these key capabilities.
12:01 - 12:31
Closing Keynote
How Pharma is fighting the fakes with blockchain technology
This talk form one of the industries most exciting blockchain innovators will help wider technology leader understand what they need to know when considering this emerging technology. Alexandru will also explore recent Pharma Industry collaboration efforts that represent a paradigm shift in the digital age while doing a deep dive into Counterfeit and how MSD is using blockchain to fight the fakes.
12:45 - 12:55
Insight Break -Closing Comments
Previous Speakers
Jacqueline T. Dioguardi
Chetak Buaria
Jack Lampka
Bharti Rai
Agam Upadhyay
Amy West
Christian Hein
Jenny Ligon
An immersive
event experience
interactive features including:
Audience Interaction
Engage with a virtual live audience just as you would at a physical event and create meaningful conversations.
Interactive Live Polling
Keep engaged through interactive live polling and gamification tools.
Direct connections
Ask your questions face-to-face with the speakers via our leading stage technology.
Relationship building
Build stronger connections with leading executives that you will take with you through your career
Thought Leadership
Content and insight from industry experts when it matters most
Intelligent interaction
Interactive quizzes gamify your experience
Related events
Have a question…
There is no cost associated with attending a GDS Summit. In return, we ask that all senior executives in participation attend for the full duration to ensure that all attendees get maximum value and insight from the interactive roundtables, live Q&As and breakout networking sessions.
Our digital summit portfolio is designed to bring together senior decision makers from large global businesses and innovative disruptor brands to drive industry forward through addressing business critical challenges collaboratively.
If you’re keen to build new connections with likeminded leaders, de-risk your projects through new insight and establish new partnerships that can accelerate your projects then apply to attend today.
Complete our form below if you’re interested in attending the summit and you meet our application criteria. A member of the GDS team will then reach out to run you through the programme and event format and discuss your participation.
On stage: co-host a panel discussion with a group of likeminded senior executives or host a solo keynote presentation. Both slots include elements of interactive audience Q&A
Off stage: become a roundtable moderator, leading the discussion with the same cohort of executives for the duration of the summit around a specific topic you’ve agreed to focus on during the roundtable session.
We can tailor a partnership package to help meet your business objectives. This might include brand awareness, driving traffic to your site or quality editorial content via exclusive interviews and Q&As with our executive audience. Enquire today for more information.